170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA
Market cap: $137.0M (2/10/2026)
Price: $0.57
Termination of Material Definitive Agreement - Vaxart, Inc.
Provides Business Update and Reports Third Quarter 2025 Financial Results
Enters Exclusive License Agreement for Novel Oral COVID-19 Vaccine Program
Reg. FD
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Other Events
Announces Adjournment of Special Meeting of Stockholders
Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Soliciting Materials
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload